AP photo
This undated image provided by Roche on Friday shows a vial and packaging for the drug Kadcyla. On Friday, the U.S. Food and Drug Administration announced the approval of the first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.
Read the article: New targeted breast cancer drug that targets tumor cells approved
